177 Glaucoma - Tips, consejos y experiencias BIBLIOGRAFÍA 1. Cedrone C, Nucci C, et al, Prevalence of glaucomatous visual field loss in an italian population:a comparison with other European studies. Eye 2006;20(6):661-7. 2. Peters D, Bengtsson B, Heijil A. Factors associated with lifetime risk of open angle glaucoma blindness.Acta Ophthalmol 2013. 3. Justiniano MJ, Olguín R, Villarroel L, Quispe E, Alvarez ML. Estado del daño glaucomatoso al momento de diagnóstico en Bolivia. Revista de la Sociedad Boliviana de Oftalmología. 2020. Investigación aún no publicada. 4. The Advanced Glaucoma Intervention Study (AGIS):7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol 2000;130(4):429-40. 5. The effectiveness of intraocular pressure reduction in the treatment of normal tensión glaucoma. Collaborative Normal Tension Glaucoma Study Group. Am J Ophthalmol 1998;126(4):498-505. 6. Kass MA, Heuer DK, et al. The Ocular Hipertension Treatment Study (OHTS). Arch Ophthalmol 2002;120(6):701-13. 7. Martus P, Stroux A et al. Predictive Factors for progressive optic nerve damage in various types of chronic open angle glaucoma. Am J Ophthalmol 2005;139(6):999-1009. 8. Terminology and guidelines for Glaucoma. The European Glaucoma Society. 2014 9. Yankelevich J, Grigera D, Casiraghi J. Concepto de Glaucoma. Glaucoma tomo I. Maestría a Distancia en Oftalmología (2006):29-35. 10. Shields MB. An Overview of Glaucoma, from Text Book of Glaucoma 5th Edition (2005). 11. Leske MC, Heijil A, Hyman L. Predictors of long-term progresion in the early manifest Glaucoma trial. Ophthalmology 2007;114(11):1965-72. 12. Jampel HD. Target pressure in Glaucoma Therapy. J Glaucoma 1997;6(2):133-8. 13. Caprioli J. Target Pressure. Ophthalmology 108 (2001):1367-8. 14. Consenso de tratamiento de Glaucoma de ángulo abierto de la Sociedad Boliviana de Glaucoma. (2016). 3er Congreso Boliviano de Glaucoma 15. Boland MV, Ervin AM, Friedman DS, et al. Comparative effectiveness of treatments for open – angle glaucoma: a systematic review for the U.S. preventive services task forcé. Ann Intern Med 2013;158(4):271-9. 16. Justiniano MJ, Loew P. Eficacia del uso de latanoprost en emulsión libre de conservantes en el Glaucoma de angulo abierto. Poster científico. Congreso Panamericano de Oftalmología Cancún 2019. 17. Latina MA, Sibayan SA, Shin DH. Q-Switched 532-nm Nd:YAG laser trabeculoplasty (Selective Laser Trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology 1998;105(11):2082-8. 18. Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg 1995;26(3):233-6. 19. Olthoff CM, Schouten JS. Noncompliance with ocular hypotensive reatments in patients with glaucoma or ocular hypertension. An evidence based review. Ophthalmology 2005;112(6):953-61. 20. Chrai SS, Makoid MC. Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. J Pharm Sci 1974;63(3):333-8. 21. Pisella PJ, Pouliquen P, Baudoin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Eur J Ophthalmol 2007;17(3):341-9.
RkJQdWJsaXNoZXIy MTYwMjk1